Path Fertility works with doctors and fertility specialists to provide couples who are trying to conceive with answers. Using breakthrough technology, Path Fertility has developed a sperm analysis test that is more predictive of pregnancy than the current standard of care semen analysis alone. SpermQT examines epigenetic biomarkers and DNA methylation within the sperm head--looking beyond typical criteria of male fertility such as sperm count, motility, and concentration. 

Despite common misconceptions, fertility problems are common (1 in 6 people) and impact both men and women equally. The gender divide in both fertility testing and treatment has left not only a gap in potential interventions, but also in the emotional burden that partners experience. Path Fertility is on a mission to raise the standard of care for male reproductive health. 

Male fertility is a women's health issue. When subfertile men go undiagnosed, women are put through fertility treatments that will not work. 

Powered by Inherent Biosciences.

Path Fertility

Org chart

Teams

Offices

Path Fertility

Org chart

Teams

Offices

Related companies